Page last updated: 2024-09-03

imatinib mesylate and Nervous System Diseases

imatinib mesylate has been researched along with Nervous System Diseases in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jaggi, AS; Kulshrestha, R; Kumar, M; Singh, N	1
Agarwal, A; Deininger, MW; Druker, BJ; Fleischman, AG; Loriaux, M; Luty, S; MacKenzie, R; Petersen, CL; Woltjer, RL	1
Ault, P; Cortes, J; Ferrajoli, A; Kaled, ES; Kantarjian, H; Koller, C; Letvak, L; Rios, MB; Thomas, D; Wierda, W	1

Reviews

1 review(s) available for imatinib mesylate and Nervous System Diseases

Article	Year
Expanding spectrum of anticancer drug, imatinib, in the disorders affecting brain and spinal cord. Pharmacological research, 2019, Volume: 143 Topics: Animals; Antineoplastic Agents; Brain; Humans; Imatinib Mesylate; Nervous System Diseases; Protein Kinase Inhibitors; Spinal Cord	2019

Trials

1 trial(s) available for imatinib mesylate and Nervous System Diseases

Article	Year
Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome. Blood, 2003, Jun-15, Volume: 101, Issue:12 Topics: Adult; Aged; Benzamides; Bone Marrow; Cardiovascular Diseases; Enzyme Inhibitors; Eosinophils; Female; Fusion Proteins, bcr-abl; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Leukocyte Count; Male; Middle Aged; Nervous System Diseases; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Remission Induction; Skin Diseases	2003

Article

Year

Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome.

Blood, 2003, Jun-15, Volume: 101, Issue:12

Topics: Adult; Aged; Benzamides; Bone Marrow; Cardiovascular Diseases; Enzyme Inhibitors; Eosinophils; Female; Fusion Proteins, bcr-abl; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Leukocyte Count; Male; Middle Aged; Nervous System Diseases; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Remission Induction; Skin Diseases

2003

Other Studies

1 other study(ies) available for imatinib mesylate and Nervous System Diseases

Article	Year
Effects of plerixafor in combination with BCR-ABL kinase inhibition in a murine model of CML. Blood, 2012, Sep-27, Volume: 120, Issue:13 Topics: Animals; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Benzylamines; Blotting, Western; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Dasatinib; Female; Flow Cytometry; Fusion Proteins, bcr-abl; Heterocyclic Compounds; Imatinib Mesylate; Immunoenzyme Techniques; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred BALB C; Nervous System Diseases; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptors, CXCR4; Thiazoles	2012

Article

Year

Effects of plerixafor in combination with BCR-ABL kinase inhibition in a murine model of CML.

Blood, 2012, Sep-27, Volume: 120, Issue:13

Topics: Animals; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Benzylamines; Blotting, Western; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Dasatinib; Female; Flow Cytometry; Fusion Proteins, bcr-abl; Heterocyclic Compounds; Imatinib Mesylate; Immunoenzyme Techniques; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred BALB C; Nervous System Diseases; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptors, CXCR4; Thiazoles

2012